
Zedem-ER 6.25 Tablet
Marketer
Ryon Pharma
Salt Composition
Zolpidem (6.25mg)
Overview Zedem-ER 6.25 Tablet
Somnus-XR 6.25 mg tablets offer short-term relief from insomnia. They shorten sleep latency and reduce nighttime awakenings, promoting consolidated sleep. Take Somnus-XR 6.25 mg on an empty stomach, ideally right before bed, consistently at the same time daily for optimal blood levels. Follow your doctor's prescribed dosage and duration; this medication can be habit-forming and should not be discontinued abruptly without medical supervision, as this may exacerbate symptoms. Potential side effects, which typically resolve spontaneously, include amnesia, visual or auditory distortions, restlessness, cephalalgia, dizziness, bowel looseness, nausea, emesis, and lower back discomfort. Fatigue, abdominal pain, diplopia, and depressive symptoms are also possible. Report any persistent or bothersome effects to your physician. Due to drowsiness and potential for vertigo, avoid driving or tasks requiring alertness until the drug's effects are known. Refrain from alcohol consumption while using this medication, as it can intensify dizziness. Report any unusual mood shifts, new or worsening depression, perceptual disturbances, or suicidal ideation to your doctor immediately. Always inform your doctor of all other medications you're using before starting Somnus-XR 6.25 mg, especially if you have hepatic or renal impairment. Smoking and alcohol should be avoided. This medication is contraindicated in pregnancy and lactation; consult your doctor if necessary.
Uses of Zedem-ER 6.25 Tablet
Managing Sleep Difficulties
Major Benefits of Zedem-ER 6.25 Tablet:
Follow your doctor's instructions or consult the product label for proper administration. Take Zedem-ER 6.25 Tablet on an empty stomach.
Common Side effects of Zedem-ER 6.25 Tablet:
- Dizziness
- Sleepiness
- Headache
- Nausea
- Stomach pain
- Memory loss
- Vertigo
- Vomiting
- Back pain
- Agitation
- Double vision
- Depression
How to use Zedem-ER 6.25 Tablet:
Follow your doctor's instructions or consult the product label for guidance. Take Zedem-ER 6.25 Tablet on an empty stomach.
How Zedem-ER 6.25 Tablet works:
SomniRest 6.25mg tablets are classified as non-benzodiazepine sleep aids. This medication exhibits hypnotic, sedative, and anticonvulsive effects, controlling seizures. Its mechanism involves interaction with the GABAA receptor chloride channel complex, a neurotransmitter receptor, to reduce neuronal activity in the brain and promote sleep onset.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Zedem-ER 6.25mg tablets and alcohol may induce significant somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Zedem-ER 6.25 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks prior to prescribing. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Zedem-ER 6.25mg tablets are compatible. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking Zedem-ER 6.25 Tablet may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Zedem-ER 6.25 Tablets without a recommended dose change. Nevertheless, kidney disease should be disclosed to your physician.
LiverCAUTION
Patients with liver impairment should use Zedem-ER 6.25 mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation at a reduced dose is typical; however, the medication is unsuitable for individuals with severe liver disease.
What if you forget to take Zedem-ER 6.25 Tablet :
Omit any missed Zedem-ER 6.25 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Zedem-ER 6.25 Tablet
| Label | Value |
|---|---|
| Chemical Category | Imidazopyridine-based compound |
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience (Central Nervous System) |
| Active Class | Non-benzodiazepine sleeping medications (Z-drugs) |
